iifl-logo

ANG Lifesciences India Ltd Board Meeting

Add as a Preferred Source on Google
₹36.2
(-12.07%)
Nov 16, 2026|04:01:00 PM

ANG Lifesciences CORPORATE ACTIONS

17/11/2025calendar-icon
17/11/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting14 Nov 20266 Nov 2026
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended September 30 2026.
Board Meeting7 Sep 20267 Sep 2026
This is to inform you, pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Board of Directors of the Company, at its meeting held today, i.e., Monday, September 07, 2026, inter alia, has taken the following decisions:- 1. The Board of Directors of the Company have considered and approved the Report of Board of Directors for the financial year ended as on March 31, 2026 under section 134 of the Companies Act, 2013. 2. The Board of Directors of the Company have considered and approved the Notice of 20th Annual General Meeting of the Company. 3. The Board has approved the day, date, time and calendar of events and Notice of 20th Annual General Meeting of the company to be held on 30th September, 2026 at 12:00 noon, through Video Conferencing (VC)/Other Audio Visual Means (OAVM) * other details as per attachment
Board Meeting14 Aug 20267 Aug 2026
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30 2026. Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on:14.08.2026)
Board Meeting30 May 202622 May 2026
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve the Standalone & Consolidated Audited Financial Results for the 4th Quarter and Financial Year Ended March 31 2026. Audited Financial Results for the quarter and year ended 31st March, 2026 (As Per BSE Announcement Dated on: 30/05/2026)
Board Meeting14 Feb 20265 Feb 2026
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on 31st December 2025. Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025 (As Per BSE Announcement Dated on: 14/02/2026)

ANG Lifesciences: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.